Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06745427
NCT06745427Not yet recruitingNot Applicable

A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia

Region Stockholm0 sites100 target enrollmentStarted: January 15, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Primary Endpoint
Relaps of endometrial cancer or EIN after fertility-sparing treatment
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia

Detailed Description

A multi-center prospective study on the oncological and reproductive outcomes and quality of life in young woman after fertility-sparing treatment of endometrial cancer and endometrial intraepithelial hyperplasia

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Fertility sparing treatment of EC and EIN.
  • •18-45 Years old
  • •From start study (Jan 2025 - end study Jan 2028)
  • •All centras in Sweden

Exclusion Criteria

  • •Not English och Swedish speaking

Outcomes

Primary Outcomes

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Time Frame: from enrollment to 2 years after fertility-sparing treatment

Relaps of endometrial cancer or EIN after fertility-sparing treatment

Secondary Outcomes

  • Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN(From start of study to 2 years after fertility-sparing treatment)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Charlotta Riese

MD

Region Stockholm

Similar Trials

Recruiting
Not Applicable
Fertility Preservation in Young Women With CancerFertilityCancer
NCT02878434University Hospital, Gasthuisberg2,000
Recruiting
Not Applicable
Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast CancerBreast Cancer Female
NCT04586686Universitair Ziekenhuis Brussel41
Recruiting
Not Applicable
Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian FunctionBenign Ovarian Cyst
NCT04643106Seoul National University Hospital90
Recruiting
Unknown
Prospective Cohort study of Female Oncofertility in OsakaAdolescent and young adult women with newly diagnosed cancer, requiring anticancer treatment
JPRN-UMIN000053453Osaka General Medical Center300
Completed
Not Applicable
A Follow-up Study of Women Evaluated and Treated for InfertilityEndometrial CancerColorectal Cancer, MelanomaBreast CancerOvarian CancerThyroid Cancer
NCT00342446National Cancer Institute (NCI)12,193